Home/Filings/4/0001209191-16-130279
4//SEC Filing

REVA Medical, Inc. 4

Accession 0001209191-16-130279

CIK 0001496268operating

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 6:03 PM ET

Size

5.0 KB

Accession

0001209191-16-130279

Insider Transaction Report

Form 4
Period: 2016-06-28
Brandom Donald K.
VP, Biomaterials Product Dev
Transactions
  • Sale

    Common Stock

    2016-06-28$7.33/sh994.6$7,28670,050 total
Footnotes (2)
  • [F1]Represents the sale of 9,946 of the Company's Chess Depository Interests (CDIs) trading on the Australian Securities Exchange ("ASX").
  • [F2]The sale was executed in the form of CDIs trading on the ASX and, as such, the sale price has been converted to a USD equivalent, adjusting for the conversion ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction.

Issuer

REVA Medical, Inc.

CIK 0001496268

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001496268

Filing Metadata

Form type
4
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 6:03 PM ET
Size
5.0 KB